Amarin Corp Plc (AMRN)

[Sam81]

MOG

Come on, you are playing around with words to try and prove what you mentioned before.

"Did Jeffries say AMRN isn't planning on, or doesn't need, any dilution in the near future?"

Did they say that they for sure, 100%, without any doubt, need financing which can dilute shareholders?????

I dunno if you are familiar with equity research reports or flash note. Usually when an analyst covering a specific stock has concerns about his valuation, he/she adds a segment underneath "Risks". I clearly don't see that in Jefferies paper

To show it to you in a very clear and smooth way so you understand what i mean:

In one of the equity updates for AMRN in May-15, underneath "Risks" the following was written:

Risks
Commercialization Risk as Standalone -
Dilution Risk from Financing -
Kowa Partnership Reduces Expenses and Enhances Sales Potential -
ANCHOR & REDUCE-IT Regulatory Approval -
Vascepa Intellectual Property Estate: Issuance of Additional Patent to Support Product Longevity -
Vascepa Supply Constraints Unlikely, but Could Occur -


" I don't see anything in the note that changes AMRN's need for financing by the end of next year (probably a lot sooner)."

I guess Goldman, Citi, MorganStanley, RBC, BoA should be harrasing you by now, knocking on your door and calling you with lucrative job offers bcz hiring you and following your logic, they will be able to make millions for their clients and for their prop books